72 studies found for:    "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency" OR "Congenital Adrenal Hyperplasia" OR "Adrenal Hyperplasia, Congenital"
Show Display Options
Rank Status Study
21 Completed Examining Genetic Differences Among People With 21-Hydroxylase Deficiency
Condition: 21-hydroxylase Deficiency
Intervention: Procedure: Hydrocortisone withdrawal
22 Completed A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency
Condition: 21-hydroxylase Deficiency
Intervention: Drug: Abiraterone acetate
23 Completed Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH
Conditions: Endocrine Disease;   Adrenal Insufficiency;   Congenital Adrenal Hyperplasia
Intervention: Drug: Hydrocortisone Modified Release Capsules
24 Completed Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: Nifedipine
25 Enrolling by invitation Natural History Study of Patients With Excess Androgen
Conditions: Congenital Adrenal Hyperplasia (CAH);   Familial Male-Limited Precocious Puberty (FMPP)
Intervention:
26 Unknown  Tweens to Teens Project at Penn State
Condition: Congenital Adrenal Hyperplasia
Intervention: Behavioral: Questionnaires/Interviews
27 Recruiting Decision Support for Parents Receiving Information About Child's Rare Disease
Conditions: Disorder of Sex Development;   Intersex Conditions;   Congenital Adrenal Hyperplasia;   Hypospadias
Intervention: Behavioral: Decision Support Tool
28 Completed Clinical Evaluation of NeoPlex4 Assay and NeoPlex System
Conditions: Adrenal Hyperplasia, Congenital;   Congenital Hypothyroidism;   Cystic Fibrosis
Intervention:
29 Withdrawn Gene Polymorphisms Influencing Steroid Synthesis and Action
Conditions: Disorders of Sex Development;   Congenital Adrenal Hyperplasia;   Congenital Adrenal Hypoplasia;   Adrenal Insufficiency;   Mineralocorticoid Deficiency;   Intersex
Intervention:
30 Unknown  Mutation Analysis of 17α-Hydroxylase
Conditions: Pseudohermaphroditism;   Congenital Adrenal Hyperplasia;   Hypertension
Intervention: Procedure: blood drawing
31 Recruiting Extension Study for Patients Entered Into Study Infacort 003
Condition: Adrenal Insufficiency
Intervention: Drug: Infacort®
32 Completed Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women
Conditions: Polycystic Ovary Syndrome;   Menstrual Pattern;   Hyperandrogenism;   Metabolic Features
Intervention: Drug: myo-inositol,alpha-lipoic acid and folic acid
33 Recruiting Acupuncture or Metformin for Insulin Resistance in Women With PCOS
Conditions: Polycystic Ovary Syndrome;   Insulin Resistance;   Hyperandrogenism
Interventions: Other: Lifestyle management;   Device: Acupuncture;   Drug: Metformin
34 Recruiting Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism;   Puberty
Intervention: Other: Phenotype/genotype assessment
35 Enrolling by invitation Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism
Interventions: Drug: metformine;   Drug: placebo;   Drug: clomiphene citrate
36 Recruiting Phlebotomy and Polycystic Ovary Syndrome
Conditions: Hyperandrogenism;   Metabolic Cardiovascular Syndrome
Interventions: Procedure: Phlebotomy;   Drug: ethinylestradiol;   Drug: Cyproterone Acetate
37 Not yet recruiting Ultrasound Three-dimensional Characterization of Ovarian Morphology in Women With Polycystic Ovary Syndrome (PCOS)
Conditions: PCOS;   Hyperandrogenism
Interventions: Procedure: Ultrasound;   Procedure: Determination of concentrations of androgens;   Device: Three dimensional ultrasound probe
38 Recruiting Assessment of Day-night Secretion of Progesterone and LH Across Puberty
Conditions: Puberty;   Hyperandrogenism
Intervention: Other: Blood sampling
39 Unknown  Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants
Conditions: Polycystic Ovarian Syndrome;   Hyperandrogenism;   Menstrual Irregularities
Interventions: Drug: 20 mcg ethinylestradiol /3 mg drospirenone;   Drug: 20 mcg ethinylestradiol/3 mg drospirenone and Selmevit;   Drug: 30 mcg ethinylestradiol/3 mg drospirenone;   Drug: 30 mcg ethinylestradiol/3 mg drospirenone and Selmevit;   Drug: 35 mcg ethinylestradiol/2 mg cyproterone;   Drug: 35 mcg ethinylestradiol/2 mg cyproterone and Selmevit
40 Completed Presentations of Hyperandrogenic Phenotypes in Taiwanese Women
Conditions: Hyperandrogenism,;   Polycystic Ovary Syndrome,;   Metabolic Syndrome,;   Insulin Resistance,;   Cardiovascular Disease.
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years